High dose chemotherapy and autologous stem cell transplantation for metastatic breast cancer: is there a place?

被引：0
作者：
Stadtmauer, EA [1 ]
机构：
[1] Univ Penn, Ctr Canc, Bone Marrow & Stem Cell Transplant Program, Philadelphia, PA 19104 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2003年 / 81卷
关键词：
high dose chemotherapy; metastatic breast cancer; stem cell transplant;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Seven comparative trials with over 2000 patients enrolled show no definitive evidence that high dose chemotherapy with stem cell support offers a survival advantage for metastatic breast cancer over conventional dose chemotherapy. Though numbers are low and small differences may exist particularly in subsets of patients, the duration of follow-up is adequate to make the likelihood of a late benefit low. High dose chemotherapy with stem cell transplantation does not have a place in the treatment of metastatic breast cancer outside of clinical trials.
引用
收藏
页码：S111 / S115
页数：5
相关论文
共 50 条
  • [41] Role of high dose chemotherapy and autologous hematopoietic stem cell transplantation in Hodgkin lymphoma
    不详
    ONCOLOGY IN CLINICAL PRACTICE, 2008, 4 : A1 - A22
  • [42] Successful Treatment with High-Dose Chemotherapy Followed by Autologous Stem-Cell Transplantation in a Patient with Metastatic Germ Cell Tumor
    Lee, Jung Min
    Kang, Byung Woog
    Han, Man-Hoon
    Baek, Dong Won
    CASE REPORTS IN ONCOLOGY, 2021, 14 (02): : 998 - 1003
  • [43] High dose chemotherapy and hematopoietic progenitor cell transplantation for breast cancer
    Pedrazzoli, P
    Tarenzi, E
    Tullio, C
    Colosini, G
    Siena, S
    JOURNAL OF CHEMOTHERAPY, 2004, 16 : 108 - 111
  • [44] Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation for metastatic breast cancer: immunologic consequences affecting clinical outcome
    Chakraborty, NG
    Bilgrami, S
    Maness, LJ
    Guo, C
    Perez-Diez, A
    Mukherji, B
    Tutschka, P
    BONE MARROW TRANSPLANTATION, 1999, 24 (08) : 837 - 843
  • [45] Paclitaxel and Trastuzumab as Maintenance Therapy in Patients with HER2-Positive Metastatic Breast Cancer Who Underwent High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation
    Cheng, Yee Chung
    Rondon, Gabriela
    Anderlini, Paolo
    Khouri, Issa F.
    Champlin, Richard E.
    Ueno, Naoto T.
    JOURNAL OF CANCER, 2013, 4 (08): : 679 - 685
  • [46] Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation for metastatic breast cancer: immunologic consequences affecting clinical outcome
    NG Chakraborty
    S Bilgrami
    LJ Maness
    C Guo
    A Perez-Diez
    B Mukherji
    P Tutschka
    Bone Marrow Transplantation, 1999, 24 : 837 - 843
  • [47] A mathematical model for reconstitution of granulopoiesis after high dose chemotherapy with autologous stem cell transplantation
    Ostby, I
    Rusten, LS
    Kvalheim, G
    Grottum, P
    JOURNAL OF MATHEMATICAL BIOLOGY, 2003, 47 (02) : 101 - 136
  • [48] A mathematical model for reconstitution of granulopoiesis after high dose chemotherapy with autologous stem cell transplantation
    Ivar Østby
    Leiv S. Rusten
    Gunnar Kvalheim
    Per Grøttum
    Journal of Mathematical Biology, 2003, 47 : 101 - 136
  • [49] High-dose chemotherapy and autologous stem cell support followed by post-transplant doxorubicin and taxol as initial therapy for metastatic breast cancer: hematopoietic tolerance and efficacy
    deMagalhaes-Silverman, M
    Hammert, L
    Lembersky, B
    Lister, J
    Rybka, W
    Ball, E
    BONE MARROW TRANSPLANTATION, 1998, 21 (12) : 1207 - 1211
  • [50] High-Dose Chemotherapy plus Stem Cell Transplantation in Advanced Germ Cell Cancer: A Review
    Connolly, Roisin M.
    McCaffrey, John A.
    EUROPEAN UROLOGY, 2009, 56 (01) : 57 - 64
12345